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Background: Australia uses acute flaccid paralysis (AFP) surveillance to monitor its polio-free status. The World
Health Organization criterion for a sensitive AFP surveillance system is the annual detection of at least one non-
polio AFP case per 100,000 children aged less than 15 years, a target Australia has not consistently achieved.
Children exhibiting AFP are likely to be hospitalised and may be admitted to an intensive care unit. This provides a
potential opportunity for active AFP surveillance.
Methods: A data-linkage study for the period from 1 January 2005 to 31 December 2008 compared 165 non-polio
AFP cases classified by the Polio Expert Panel with 880 acute neurological presentations potentially compatible with
AFP documented in the Australian and New Zealand Paediatric Intensive Care (ANZPIC) Registry.
Results: Forty-two (25%) AFP cases classified by the Polio Expert Panel were matched to case records in the
ANZPIC Registry. Of these, nineteen (45%) cases were classified as Guillain-Barré syndrome on both registries. Ten
additional Guillain-Barré syndrome cases recorded in the ANZPIC Registry were not notified to the national AFP
surveillance system.
Conclusions: The identification of a further ten AFP cases supports inclusion of intensive care units in national AFP
surveillance, particularly specialist paediatric intensive care units, to identify AFP cases that may not otherwise be
reported to the national surveillance system.
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The Global Polio Eradication Initiative has made tre-
mendous progress towards the goal of eradicating polio
worldwide. In 1988, at the time of the initiative’s incep-
tion, there were more than 350,000 polio cases reported
from 125 countries [1]. In 2013, only three countries re-
main endemic: Afghanistan, Nigeria and Pakistan. India
was removed from the list of endemic countries in
January 2012 after remaining polio-free for one year,
which was a monumental achievement for the polio* Correspondence: Linda.Hobday@mh.org.au
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reproduction in any medium, provided the oreradication program [2]. The World Health Organization
(WHO) Western Pacific region, which includes Australia,
was certified polio-free in 2000 [3]. However, the region
remains vulnerable to importation of wild poliovirus, as
occurred in China during 2011 [4] and Australia in July
2007, with disease confirmed in a 22 year old student
returning from Pakistan [5]. Australia has used inactivated
polio vaccine exclusively since November 2005, which is
funded under the National Immunisation Program (NIP)
for children. The WHO recommends that all polio non-
endemic countries conduct acute flaccid paralysis (AFP)
surveillance in children less than 15 years of age to moni-
tor and verify polio-free status. The WHO has defined a
non-polio background AFP surveillance rate that serves tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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surveillance. To maintain WHO certification as polio-free,
Australia is expected to:
1) detect at least one case of non-polio AFP for every
100,000 children less than 15 years of age annually;
2) collect two faecal specimens greater than 24 hours
apart and within 14 days of the onset of paralysis,
from at least 80% of AFP cases; and
3) submit all specimens for processing to a WHO
accredited laboratory [6].
AFP is a clinical manifestation of many conditions, in-
cluding poliomyelitis. The WHO have described AFP as
a “syndrome characterised by rapid onset of weakness of
an individual’s extremities, often including weakness of
the muscles of respiration and swallowing, progressing
to maximum severity within 1–10 days. The term ‘flac-
cid’ indicates the absence of spasticity or other signs of
central nervous motor system involvement, including
hyperflexia, clonus, or extensor plantar responses [7]”. It
is imperative to exclude poliovirus as the causative agent
of the paralysis.
Each reported case of AFP is reviewed and classified
by the national Polio Expert Panel (PEP). The most com-
mon cause of non-polio AFP between 1995 and 1999 in
Australia was Guillain-Barré syndrome (GBS) [8]. In the
same period, 137/143 (96%) of the non-polio AFP cases
were hospitalised.
Whitfield and Kelly conducted a two source capture
recapture analysis to estimate the incidence of AFP in an
Australian jurisdiction (Victoria) for the years 1998–
2000 using the national AFP surveillance system, as used
in this current study, and hospital discharge records [9].
They concluded that AFP surveillance in that jurisdic-
tion was insensitive with only 35% of the total number
of cases identified reported to the national scheme. From
late 2007, the AFP surveillance scheme was comple-
mented by hospital based nurses at four major tertiary
paediatric hospitals identifying AFP cases and the target
non-polio AFP detection rate has been achieved on nine
occasions in Australia since it was established in 1995
and consecutively from 2008 to 2012. Adequate stool
specimen collection has never been accomplished in
Australia, with collection occurring from approximately
30% of AFP cases reported each year (Hobday LK, un-
published data). This sub-optimal performance in viro-
logical examination of stool specimens from AFP cases
potentially compromises the sensitivity of Australia’s sur-
veillance to detect an imported case of polio and to ex-
clude poliovirus infection [10].
Data from the World Health Organization Western
Pacific Region (WPR) for the years 2005 to 2008 in-
clusive show that the region had variable success inreaching the WHO surveillance targets for non-polio
AFP rate and stool collection criteria. On average for the
entire Western Pacific region, 74% of the countries satis-
fied the non-polio AFP notification criteria on a year to
year basis while 41% of the countries achieved the stool
collection criteria [11]. For example, publications from
Hong Kong and Malaysia, within the WPR, and the
Netherlands and Italy reported more success achieving
the non-polio AFP notification target but were incon-
sistent in meeting the stool collection criteria [12-15].
Therefore AFP cases are being ascertained worldwide by
the surveillance systems but virological testing to ex-
clude poliovirus infection is challenged. For this reason,
not all countries have adopted AFP surveillance; Finland
chose to employ enterovirus and environmental surveil-
lance in preference to AFP surveillance due to inadequa-
cies and lack of sensitivity using a clinical surveillance
scheme [16].
Given the acute and dramatic nature of children pre-
senting with AFP, a hypothesis of this study was that a
high proportion of AFP cases would be admitted to an
intensive care unit (ICU) due to concerns of progressive
paralysis, including respiratory paralysis, and the need
for specialised care. Additionally the project aimed to
investigate whether the Australian and New Zealand
Paediatric Intensive Care (ANZPIC) Registry could iden-
tify AFP cases admitted to ICUs but which were not no-
tified through the national AFP surveillance system. The
ANZPIC Registry was established in 1997 [17]. Partici-
pating ICUs submit case records of an agreed dataset for
all children admitted to an ICU in their institution. The
system includes codes to classify the reason for admis-
sion and associated diagnoses. Could ICUs through the
ANZPIC Registry, provide a further opportunity to
identify unreported AFP cases and thus enhance AFP
surveillance in Australia, consequently improving our
ability to achieve the recommended WHO AFP surveil-
lance indicators? To our knowledge this is the first study
to investigate the integrity of an intensive care registry
to identify AFP cases.Methods
Generation of the AFP and ANZPIC datasets
The data for the linkage study originated from two
sources; the national AFP database held at the Victorian
Infectious Diseases Reference Laboratory and the
ANZPIC Registry held by the Australian and New
Zealand Intensive Care Society. AFP notifications are
timely, usually within one month of the onset of par-
alysis, while ANZPIC data is currently submitted to
the Registry biannually [18]. For the purposes of this
study, the diagnosis assigned to the case by the PEP
was accepted as the definitive diagnosis.
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AFP surveillance was initiated in 1995 by the Australian
Government in collaboration with the Australian Paed-
iatric Surveillance Unit (APSU) in response to the World
Health Organization’s recommendation to conduct AFP
surveillance as part of the global polio eradication
initiative [19]. From 2000, AFP surveillance has been co-
ordinated by the National Enterovirus Reference Labora-
tory at the Victorian Infectious Diseases Reference La-
boratory in Melbourne, Australia, in association with the
APSU. The APSU facilitates active surveillance of un-
common childhood diseases. Paediatricians return a
monthly report card to the APSU indicating if they have
diagnosed a case of AFP or other specified clinical pre-
sentations. The APSU shares the notification of all AFP
cases with the national AFP surveillance co-ordinator
who requests the treating doctor to complete a clinical
questionnaire that enables the PEP to review the case
based on the outcomes of clinical and virological investi-
gations. An additional source of AFP notifications is
through Paediatric Active Enhanced Disease Surveillance
(PAEDS), which was established in tertiary paediatric
hospitals in four states of Australia (New South Wales,
South Australia, Victoria and Western Australia) during
September 2007 [20]. PAEDS nurses identify AFP cases
and report them directly to the national AFP surveil-
lance co-ordinator for review by the PEP. A third source
of AFP surveillance is direct notification of cases to the
National Enterovirus Reference Laboratory. The final
AFP case classifications, epidemiological data and la-
boratory results are reported to the WHO for inclusion
in the Western Pacific Weekly Epidemiological Report.AFP dataset
Cases of non-polio AFP between 2005 and 2008 were in-
cluded in the AFP dataset. The initial dataset comprised
188 cases but exclusions were imposed for patients who
were 15 years of age or older (n=18) and non-Australian
residents (n=5). One hundred and sixty-five unique AFP
cases involving a child less than 15 years of age were
identified.ANZPIC registry
During the study period, up to 23 Australian and New
Zealand ICUs contributed to the ANZPIC Registry in-
cluding all eight specialist paediatric intensive care units
(PICUs). PICUs submit data for all admissions, and
other contributing ICUs submit data for all admissions
for patients less than 16 years of age. During the period
of the study, it is estimated that admissions submitted to
the ANZPIC Registry comprised 94% of paediatric ad-
missions to all Australian and New Zealand ICUs [21].
The aims of the uniform system of reporting are to: describe paediatric intensive care practices and
outcomes in Australia and New Zealand;
 provide contributing units with efficacy and
efficiency reports that compare their performance
against national and international standards; and
facilitate research in paediatric intensive care [16].ANZPIC dataset
The ANZPIC Registry uses ‘diagnostic codes’ grouped
according to designated major categories to record the
clinical diagnosis of children admitted to intensive care.
Cases entered into the ANZPIC Registry are assigned
one or more diagnoses, as appropriate. Codes for spe-
cific microbiologic organisms (such as enterovirus) are
assigned based on confirmed laboratory results. Selec-
tion of ANZPIC data was performed by filtering for case
records submitted to the registry using eight specific
diagnostic codes considered compatible with acute neu-
rological presentation with limb weakness. The diag-
nostic codes selected were: GBS, botulism, myasthenia
gravis, spinal cord lesion, myopathy, neuropathy, entero-
virus and neurological-other. The designated cases were
checked for multiple ICU admissions using the ANZPIC
identifiers of date of birth, residential postcode and hos-
pital, with only the initial admission included in the
study. Patients aged 15 years or older and patients ad-
mitted to ICUs in New Zealand were excluded. There
were 880 unique ICU admission records identified in the
ANZPIC Registry with acute neurological diagnoses.
While cases from ANZPIC originated from both general
ICUs and specialist PICUs, 92% of cases analysed in this
study originated from the latter.Data-linkage
The characteristics of both datasets were examined for
gender, age distribution, year of onset/admission and
postcode. The proportion of females was 50% in the
AFP dataset and 44% in the ANZPIC dataset (Table 1).
The proportion of cases by age-groups (0–4, 5–9, 10–
14 years of age) in the two datasets were; 43%, 27% and
30% for the AFP surveillance notifications and 50%, 24%
and 26% for ANZPIC admissions. The annual number of
AFP notifications ranged from 30 to 61 (median 37).
The peaks of AFP notification in 2006 (42) and 2008
(61) coincided with the years that Australia successfully
met the WHO performance target while the number of
AFP cases notified decreased to 30 and 32 for 2005 and
2007, respectively. Annual ANZPIC admissions for the
selected diagnoses were relatively steady for 2005, 2007
and 2008 with a peak in 2006 of 249 admissions (range:
203–249 admissions, median 214). The linkage of data
was performed using the following identifiers: date of
birth, gender and postcode.
Table 2 Diagnoses of cases linked between the national




Spinal cord injury1 4
Acute disseminated encephalomyelitis 3
Cord compression 2
Infant botulism 2
Spinal muscular atrophy 2
Tick bite paralysis 2
Leigh's encephalopathy 1
Spinal cord lesion (traumatic myelopathy) 1
Total 42
1 Four cases of ‘spinal cord injury’ were classified by the Polio Expert Panel but
do not fulfil the strict interpretation of the WHO AFP case definition.
Table 1 Description of AFP and ANZPIC datasets used for
data-linkage
AFP ANZPIC








AFP notifications versus ANZPIC
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The linked cases were further scrutinised by comparing
the date of onset of paralysis to the date of hospital ad-
mission. Three cases were excluded as the date of hos-
pital admission was more than four months after the
date of onset of paralysis.
Ethics
Ethics approval for accessing the ANZPIC Registry data
and national AFP surveillance data was granted by the
Queensland Children’s Health Services District Ethics
Committee (Royal Children’s Hospital, Brisbane) and the
Ethics Committee within the Australian Government’s
Department of Health and Ageing. Both data reposito-
ries contained only de-identified data.
Results
Linked cases
Forty-two unique cases were linked between the national
AFP database and the ANZPIC Registry. This repre-
sented 25% of the total AFP cases classified between
2005 and 2008. Of the 42 linked cases, 19 (45%) were
classified by the PEP as GBS, six (14%) as transverse
myelitis and three (7%) as acute disseminated encephalo-
myelitis (ADEM), collectively accounting for two thirds
of the cases (Table 2). Four cases of ‘spinal cord injury’
were classified by the PEP at the time but do not fulfil
the strict interpretation of the WHO AFP case defin-
ition. Thirty-eight (90%) of the linked cases originated
from a specialist PICU. Adequate stools were collected
from eight (42%) of the GBS cases, two (33%) of the
transverse myelitis cases but none from the ADEM
cases. A further two cases with the diagnoses of spinalcord injury and spinal muscular atrophy also had ad-
equate stools collected. In total, 12 (29%) of the linked
cases satisfied the WHO criteria for adequate stool
collection.Unlinked cases
Investigation of the diagnostic codes assigned to the un-
linked ANZPIC cases identified a further ten cases of
GBS that had not been notified to the AFP surveillance
co-ordinator. The only myasthenia gravis case notified
to the AFP surveillance system was not identified in the
ANZPIC registry. Twelve patients diagnosed with myas-
thenia gravis were admitted to ICUs but it could not be
determined with certainty if any represented the first
clinical manifestation rather than treatment for an existing
condition.Enteroviruses
‘Enterovirus’ is an ANZPIC diagnostic code of interest
for poliovirus/enterovirus surveillance since poliovirus
can cause meningitis and other non-paralytic conditions.
For this reason, many countries, including Australia,
perform enterovirus surveillance as a supplement to
AFP surveillance to monitor their polio-free status. There
were 21 cases of the 880 selected from the ANZPIC
Registry which were recorded with enterovirus infec-
tion. Only one of the 21 cases was reported to the
national AFP surveillance system and was classified as
transverse myelitis. Four of the remaining 20 unre-
ported enterovirus cases had an admission code of
‘meningitis’ and a further six were either ‘encephalitis’
or ‘encephalopathy’. The remaining enterovirus cases
had accompanying codes including ‘seizures’, ‘respira-
tory failure’, ‘spinal cord lesion’ and ‘myocarditis’.
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This study investigated whether AFP cases were likely to
be admitted to an ICU or PICU and whether there were
cases recorded in the ANZPIC Registry that had not
been notified to the national AFP surveillance system.
Forty-two unique cases were linked between the data-
bases indicating that 25% of the total AFP cases in the
national dataset included in this study were admitted to
a general or specialist ICU.
This finding did not confirm the investigators’ hypo-
thesis that a high proportion of AFP cases in children
would be admitted to an ICU or specialist PICU.
Ten additional GBS cases that had not been identified
by the existing national AFP surveillance system were
found. The GBS cases are of special interest since this
was the most common diagnosis attributed to non-polio
AFP cases in Australia in 1995–1999 [8]. If the ten un-
linked cases had been reported to the national AFP sur-
veillance program it would have increased the number
of GBS cases detected from 19 to 29 cases. The inclu-
sion of the previously unidentified AFP cases to the data
when Australia did not meet the WHO target (2005 and
2007) improved Australia’s surveillance performance. Al-
though the target rate of 1.0 per 100,000 children less
than 15 years old was still not achieved, the adjusted
rates for 2005 and 2007 were increased from 0.78 to
0.85 and 0.88 to 0.95 respectively. Thus, reporting AFP
cases from within ICU settings could improve the na-
tional AFP notification rate.
Myasthenia gravis is a rare auto-immune disease that
can require on-going medical care. AFP surveillance is
focused on patients presenting with syndromic symp-
toms for the first time and not related to a previously di-
agnosed condition. Eleven of the 12 patients listed in the
ANZPIC registry with myasthenia gravis also had diag-
noses indicative of elective treatment or an acute exacer-
bation of their existing condition. While the remaining
patient had myasthenia gravis listed as the only reason
for admission, the case was not counted as unlinked
with AFP surveillance as it could not be confirmed that
the condition was previously undiagnosed from the in-
formation in the registry. One case of myasthenia gravis
was notified to the AFP surveillance scheme in 2007
even though it was not listed on the clinical question-
naire. As a result of this study the PEP resolved to
include ‘myasthenia gravis’ on the questionnaire as a dif-
ferential diagnosis for causes of AFP.
The medical conditions of children with AFP, and es-
pecially those within an ICU, may impact on their ability
to produce stool samples but specimens were received
from 14 of the 19 linked GBS cases, although specimens
from only eight (42%) cases were adequate according to
the WHO recommended criteria. The percentage of
linked cases with adequate stools collected (29%) wassimilar to the average of the national AFP data (33%) for
the years of the study, 2005 to 2008 (Hobday LK, unpub-
lished data).
A limitation of the study was the inability to directly
compare the selected ANZPIC codes with AFP diagno-
ses assigned by the PEP. GBS is an admission code on
the ANZPIC Registry and so could be linked with the
AFP database directly. Transverse myelitis and ADEM
represent the second and third most common cause of
non-polio AFP, respectively, in Australia after GBS.
However, analysis for transverse myelitis and ADEM
cases was limited due to these specific diagnoses not be-
ing nominated as diagnostic codes on the ANZPIC
Registry. Two of the six linked transverse myelitis cases
had ‘spinal cord lesion’ as an ANZPIC admission code
while one of the three ADEM cases notified through the
AFP surveillance system was registered as a ‘spinal cord
lesion’. Examination of the unlinked ANZPIC data re-
vealed 66 cases which had been admitted to PICU with
the code ‘spinal cord lesion’ and it is postulated that a
portion of these cases could be transverse myelitis or
ADEM cases. Based on the results of this study, trans-
verse myelitis and ADEM were added to the list of
ANZPIC Registry diagnostic codes from 2012.
ICU admission records are currently submitted to the
ANZPIC Registry biannually. Therefore this process will
not enhance real time surveillance for ascertainment of
AFP cases. The results of this study, however, provide an
opportunity to raise awareness and motivate improved
compliance with AFP reporting and stool collection
amongst intensive care clinicians. Use of the data linkage
methods we describe to periodically audit reporting and
stool collection rates for AFP cases admitted to specialist
PICUs may serve to maintain awareness and thereby im-
prove Australia’s performance in meeting the WHO sur-
veillance targets.Conclusions
The study indicates that the majority of hospitalised
children with AFP are not admitted to intensive care
units. Nevertheless, the ANZPIC Registry is a valuable
source for identifying additional AFP cases which have
not been notified to the national AFP surveillance sys-
tem. This is especially true for GBS. The addition of
‘transverse myelitis’ and ‘acute disseminated encepha-
lomyelitis’ as diagnostic codes will align the ANZPIC
Registry with the three most common causes of non-
polio AFP reported in Australia; GBS, transverse myelitis
and ADEM. The study highlights the need to increase
awareness of the AFP surveillance program in ICUs, par-
ticularly specialist PICUs. Periodic audit could provide
feedback on the effectiveness of surveillance within
Australian ICUs.
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